Thank you to all who supported the Hour of Power Relay by swimming, cheering us on or through a donation. It was an amazing event and we are so grateful for everyone's love and support!
The Franklin Family
Second Annual Hour of Power Relay
Hosted by Holy Angels-Minnehaha Academy Swim Team and the Franklin family
When: Tuesday, November 14th 2017
Where: University of St. Thomas Pool
Time: 5:45 pm Check-in, 6-7 pm Swim
Ways to Join In:
1. SWIM! Come with your suit and goggles (all swimming levels welcome).
Swimmers will be divided into teams and swim relays for one hour.
2. CHEER! Support our swimmers!
3. RAISE AWARENESS! Hand out Rein in Sarcoma brochures
Proceeds will benefit the Ted Mullin Foundation which supports sarcoma research and the introduction of new therapies for treatment of sarcoma at the University of Minnesota.
This month, we would like to recognize Sarah Giga, a long time RIS Board member and passionate leader. Sarah has been engaged with RIS from the beginning as a friend of Karen Wyckoff’s big brother, Peter. Sarah was a charter member of the Board of Directors.
Over a dozen years she served in many positions including as Vice-President of the board. She has been instrumental in facilitating Rein in Sarcoma strategic planning process and the development of two organizational long term plans. Sarah currently serves as a key member of our Talent and Resources (personnel) Committee and has been closely involved in the hiring, evaluating, and support our staff, including our new Executive Director, Janelle Calhoun.
Sarah helped with our signature event, Party in the Park, for many years as our merchandise chair and also helped to secure our ice cream vendor, which we have continued to utilize each year. To help our outreach efforts, Sarah created our Facebook page over six years ago; it has since grown to over 2,000 followers.
In real life, Sarah works for Children’s Hospitals and Clinics and Minnesota and with her husband, Mike, lives in Roseville. We thank Sarah for her time, passion, wisdom, and dedication to RIS!
RIS Board member, Dr. Larry Seymour made a major announcement at our fall Fundraiser in Minneapolis of the 2017 awarding of $65,000 in new sarcoma research grants to Children’s Hospitals and Clinics of Minnesota, the Mayo Clinic and SARC in Michigan. The evening also included a new commitment to increase sarcoma research funding at the University of Minnesota to over $140,000 in 2018.
Upon the review and recommendations of the RIS Research Task Force, chaired by Dr. Seymour, to the RIS Board of Directors, RIS committed a $25,000 to Mayo Clinic for a research “Targeting Autophagy as a Therapeutic Strategy in Osteosarcoma” with principal investigator Avudaiappan Maran, Ph.D, Associate Professor of Orthopedics and Biomedical Engineering; and Co-investigator: Michael J. Yaszemski, M.D., Ph.D, Professor of Orthopedics and Biomedical Engineering.
Children's Hospitals and Clinics:
In addition Rein in Sarcoma is awarding Children’s Hospitals and Clinics a grant of $15,000 on “Improving outcomes for DICER1 related sarcomas” with principal investigators Kris Ann Schultz, MD Pediatric Oncologist and Co- Investigator D. Ashley Hill, MD.
RIS also committed $25,000 over five years to SARC (Sarcoma Alliance for Research through Collaboration) in Ann Arbor, Michigan in support of four core SPORE projects and based continued funding if funded by National Institute of Health (NIH). The projects are:
Project 1: Exploiting the Ability of Radiation Therapy to Activate the Immune System to Prevent Metastasis in Soft Tissue Sarcoma
Project 2: NF-1 Associated Nerve Sheath Tumors: Biology, Therapies, Prevention
Project 3: Developing Novel Therapies for the Treatment of Epithelioid Hemangioendothelioma
Project 4: Targeting Misassembled mSWI/SNF (BAF) Complexes in Human Synovial Sarcoma
NIH SPORE (Specialized Programs of Research Excellence) grants are multi-million dollar grants designed to bring cutting edge cancer research to the bedside within five years. If approved by the NIH in 2018, the research will be conducted by several major medical research institutions across the country. RIS commitments beyond 2017 are contingent upon NIH SPORE funding in 2018. Read information about the current Sarcoma SPORE project at SARC.
These three grants are a significant milestone in the growth and development of Rein in Sarcoma and are the first sarcoma research grants beyond the University of Minnesota, to which RIS remains strongly committed.